Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function, and Chronic Obstructive Pulmonary Disease in Smokers

Medicine & Life Sciences

• IgA receptor 100%
• Surface-Active Agents 79%
• Chronic Obstructive Pulmonary Disease 67%
• Smokers 64%
• Congenital Deficiency of Pulmonary Surfactant Protein B 47%
• Lung 40%
• Mutation 28%
• Spirometry 27%
• Smoking 27%
• Genotype 18%
• Newborn Respiratory Distress Syndrome 17%
• Tobacco Smoking 14%
• Lung Diseases 11%
• Hospitalization 9%
• Odds Ratio 8%
• Genes 5%
• Population 4%